Another negative AF ablation trial, predictin...
Familial hypercholesterolemia, cardiac arrest...
Renal denervation, the obesity paradox, JACC ...
Alcohol and cancer, GLP-1 trial representativ...
Listener feedback, multiple studies in AF abl...
US doc's pay, the ticagrelor controversy and ...
Tirzepatide vs semaglutide in obesity; GLP1a ...
An AHA review: the OPTION, SUMMIT, VANISH 2, ...
Tirzepatide, AF screening, and an AHA preview...
The EARLY TAVR trial, colchicine after MI, an...